Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.41 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.41 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.41 |
| ▸ | DPP4 | P27487 | 1/20 | 0.38 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.37 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.37 |
| ▸ | ADRB2 | P07550 | 3/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL677798 | 0.94 | MAPK1 (0.40) | MAPK1SMN1; SMN2NPC1LMNACASP3 | |
| SCHEMBL10438750 | 0.85 | PDCD1 (0.37) | MAPK1SMN1; SMN2NPC1LMNACASP3 | |
| SCHEMBL22432024 | 0.85 | NOTUM (0.39) | MAPK1SMN1; SMN2NPC1LMNACASP3 | |
| SCHEMBL9695975 | 0.85 | PDCD1 (0.37) | MAPK1SMN1; SMN2NPC1LMNACASP3 | |
| SCHEMBL27797465 | 0.85 | ABL1 (0.44) | MAPK1SMN1; SMN2NPC1LMNACASP3 | |
| SCHEMBL8679025 | 0.84 | DPP4 (0.35) | MAPK1SMN1; SMN2DPP4PDCD1CD274 | |
| SCHEMBL26632610 | 0.83 | HNF4A (0.43) | MAPK1SMN1; SMN2NPC1LMNACASP3 | |
| SCHEMBL31510648 | 0.83 | HNF4A (0.43) | MAPK1SMN1; SMN2NPC1LMNACASP3 | |
| SCHEMBL8679597 | 0.83 | DPP4 (0.42) | MAPK1SMN1; SMN2DPP4PDCD1CD274 | |
| Sulfuric Acid SCHEMBL6511524 | 0.83 | PTGS2 (0.41) | MAPK1SMN1; SMN2NPC1LMNACASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104053663-B | Process for purifying organodiphosphite compounds | 巴斯夫欧洲公司 | 2017-07-04 | — | — | CN | claimed |
| EP-2369670-B1 | Non-aqueous electrolytic solution for lithium secondary battery and lithium secondary battery using the same | UBE INDUSTRIES (JP) | 2016-03-23 | — | — | EP | claimed |
| EP-1650826-B1 | NONAQUEOUS ELECTROLYTIC SOLUTION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY USING SAME | UBE INDUSTRIES (JP) | 2013-05-01 | — | — | EP | claimed |
| EP-1691441-B1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND LITHIUM SECONDARY BATTERY COMPRISING THE SAME | UBE INDUSTRIES (JP) | 2012-03-07 | — | — | EP | claimed |
| US-7794885-B2 | Non-aqueous electrolytic solution and lithium secondary battery | UBE INDUSTRIES, LTD. (JP) | 2010-09-14 | — | — | US | claimed |
| US-20070082271-A1 | Non-aqueous electrolytic solution and lithium secondary battery | UBE INDUSTRIES, LTD. (JP) | 2007-04-12 | — | — | US | claimed |
| EP-1691441-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND LITHIUM SECONDARY BATTERY | Ube Industries, Ltd. (JP) | 2006-08-16 | — | — | EP | claimed |
| US-12100809-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-09-24 | — | — | US | disclosed |
| US-20220149436-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-05-12 | — | — | US | disclosed |
| US-11283107-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-03-22 | — | — | US | disclosed |
| EP-3621141-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2020-03-11 | — | — | EP | disclosed |
| US-20190292196-A1 | MODULATORS OF THE BETA-3 ADRENERGIC RECEPTOR USEFUL FOR THE TREATMENT OR PREVENTION OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. | 2019-09-26 | — | — | US | disclosed |
| US-20190229372-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2019-07-25 | — | — | US | disclosed |
| EP-1650826-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY USING SAME | Ube Industries, Ltd. (JP) | 2006-04-26 | — | — | EP | disclosed |
| US-5817251-A | AROMATIC HYDROCARBON LUBRICANT | NIPPON OIL CO., LTD. (JP) | 1998-10-06 | — | — | US | disclosed |
| US-5711895-A | Fluid composition for use in a refrigerating machine in which the refrigerating machine oil is at least one hydrocarbon compound of a formula consisting of two phenyl groups joined through an alkylene or alkenylene group | NIPPON OIL CO., LTD. (JP) | 1998-01-27 | — | — | US | disclosed |
| EP-0717098-A2 | A refrigerating machine oil and a fluid composition for use in a refrigerating machine | NIPPON OIL CO. LTD. (JP) | 1996-06-19 | — | — | EP | disclosed |
| EP-0381779-B1 | PRESSURE-SENSITIVE COPYING MATERIAL | NIPPON PETROCHEMICALS CO LTD (JP) | 1994-11-17 | — | — | EP | disclosed |
| US-5214021-A | Color former solvent of hydrogenated oligomers of propylene and butene, aromatic hydrocarbons, chlorinated paraffins; aromatic carboxylic acid or salt, metallized carboxy-modified terpene phenolic resin developers; high speed, low cost | NIPPON PETROCHEMICALS CO., LTD. (JP) | 1993-05-25 | — | — | US | disclosed |
| EP-0381779-A1 | PRESSURE-SENSITIVE COPYING MATERIAL | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1990-08-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190292196-A1 | MODULATORS OF THE BETA-3 ADRENERGIC RECEPTOR USEFUL FOR THE TREATMENT OR PREVENTION OF DISORDERS RELATED THERETO | ADRB3, ADRB1, ADRB2 | MAPK1 2226/4885SMN1; SMN2 4018/4885NPC1 786/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.